HealthQuill Articles by: HealthQuill
US-based Neurocrine Biosciences’ trial drug for treating schizophrenia reduced the severity of the disease symptoms in a mid-stage study of 210 adult participants.
Drugs Health Pharma

Neurocine’s mid-stage trial drug cuts schizophrenia severity symptoms

US-based Neurocrine Biosciences’ trial drug for treating schizophrenia reduced the severity of the disease symptoms in a mid-stage study of 210 adult participants.

Read More
An intensifying culture of comparison, that defines success and fulfilment, is behind unrealistic expectations that US parents and kids are forced to chase and this has left many families “exhausted, burned out and perpetually behind,” according to a surgeon general’s advisory.
Drugs Health Pharma

‘Culture of comparison’ fuelling parental stress: US Surgeon General

An intensifying culture of comparison, that defines success and fulfilment, is behind unrealistic expectations that US parents and kids are forced to chase

Read More
The US Federal Drug Administration approved Illumina Inc.’s DNA sequencing cancer tests that check more than 500 genes in a tumour to help find targeted therapy options.
Drugs Health Pharma

Illumina’s DNA sequencing cancer tests to check 500 genes get US nod

The US Federal Drug Administration approved Illumina Inc.’s DNA sequencing cancer tests that check more than 500 genes in a tumour to help

Read More
The World Health Organization has appealed for $87.4 million over the next six months to stop and contain the current global outbreak of mpo
Drugs Health Pharma

Global health body appeals for $87.4 million to contain mpox spread

The World Health Organization has appealed for $87.4 million over the next six months to stop and contain the current global outbreak of

Read More
McKesson Corporation, the ninth-largest company by revenue in the US, will acquire Community Oncology Revitalization Enterprise Ventures, for $2.4 billion in cash to expand its oncology portfolio.
Drugs Health Pharma

McKesson Corp., to acquire Core Ventures for $2.4 billion in cash

McKesson Corporation, the ninth-largest company by revenue in the US, will acquire Community Oncology Revitalization Enterprise Ventures, for $2.4 billion in cash to expand its

Read More
Insulet Corporation, a tubeless insulin pump maker, got clearance from the US Food and Drug Administration to add diabetes type 2 adult patients 18 years or older, to the treatment regime.
Drugs Health Pharma

Regulator okays Insulet’s insulin pump in US to treat type 2 diabetes

Insulet Corporation, a tubeless insulin pump maker, got clearance from the US Food and Drug Administration to add diabetes type 2 adult patients

Read More
Being popular means being louder. An actor, musician, sportsperson or politician opening up about his or her mental health is better heard than an ordinary individual.
Drugs Health Pharma

Celebrity backing may change societal stigma linked with mental illness

Being popular means being louder. An actor, musician, sportsperson or politician opening up about his or her mental health is better heard than

Read More
A 30-year-old male, who stayed for two weeks in Uganda, has tested positive for mpox in the Central African nation of Gabon, the country’s health minister said.
Drugs Health Pharma

Gabon reports first case of mpox, Burundi worst-hit in African continent

A 30-year-old male, who stayed for two weeks in Uganda, has tested positive for mpox in the Central African nation of Gabon, the

Read More
Environmental micro and nanoplastics (MNPs) accumulate in the human brain and total mass concentrations have risen by more than 50% in the past eight years, a study reveals.
Drugs Health Pharma

‘Shard-like plastic remnants’ of varying sizes amass in the brain: UNM

Environmental micro and nanoplastics (MNPs) accumulate in the human brain and total mass concentrations have risen by more than 50% in the past

Read More
Tome Biosciences, a US company engaged in gene editing, will lay off 131 employees as it plans to reduce costs, according to a Worker Adjustment and Retraining Act filing with the Massachusetts government.
Drugs Health Pharma

US-based Tome Biosciences to retrench 131 employees 

Tome Biosciences, a US company engaged in gene editing, will lay off 131 employees as it plans to reduce costs, according to a

Read More
X